Evidence map›Paper›PMID 32175275›Full record

ArticleFrontiers in oncology2020

Rui Zhang, Yan Zhang, Xianglan Lu, Weihong Xu, He Wang, Wenbin Mo, Hui Pang, Rurong Tang, Shibo Li, Xiaojing Yan and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. The role of SPRED1 mutation in melanoma.European journal of medical research · 2025
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Rui ZhangDepartment of Hematology, The First Affiliated Hospital of China Medical University, Shenyang, China.
Yan ZhangDepartment of Hematology, The First Affiliated Hospital of China Medical University, Shenyang, China.
Xianglan LuDepartment of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Weihong XuDepartment of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
He WangDepartment of Hematology, The First Affiliated Hospital of China Medical University, Shenyang, China.
Wenbin MoDepartment of Hematology, The First Affiliated Hospital of China Medical University, Shenyang, China.
Hui PangDepartment of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Rurong TangDepartment of Anesthesiology, The First Affiliated Hospital of China Medical University, Shenyang, China.
Shibo LiDepartment of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Xiaojing YanDepartment of Hematology, The First Affiliated Hospital of China Medical University, Shenyang, China.
Yan LiDepartment of Hematology, The First Affiliated Hospital of China Medical University, Shenyang, China.
China Medical University · CNUniversity of Oklahoma Health Sciences Center · USFirst Hospital of China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report herein that Sprouty-Related EVH1 Domain-Containing Protein1 (

Indexed as

AMLMAPKMIR126non-APLSPRED1

Identifiers

PMID32175275
PMCPMC7056905
OpenAlexW3008729536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.